國家衛生研究院 NHRI:Item 3990099045/8335

NHRI > Institute of Biotechnology and Pharmaceutical Research > Teng-Kuang Yeh > Periodical Articles > Item 3990099045/8335

Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/8335

Title:	1-Arylsulfonyl-5-(N-hydroxyacrylamide)tetrahydroquinolines as potent histone deacetylase inhibitors suppressing the growth of prostate cancer cells
Authors:	Liu, YM;Lee, HY;Chen, CH;Lee, CH;Wang, LT;Pan, SL;Lai, MJ;Yeh, TK;Liou, JP
Contributors:	Institute of Biotechnology and Pharmaceutical Research
Abstract:	This study describes the development of a series of 1-arylsulfonyl-6- (N-hydroxyacrylamide)tetrahydroquinolines, potent histone deacetylase (HDAC) inhibitors which are cytotoxic to PC-3 cells. (E)-N-hydroxy-3-(1-(4-methoxyphenylsulfonyl)-1,2,3,4- tetrahydroquinolin-6-yl)acrylamide (11) exhibits marked anti-HDAC and antiproliferative activity, and is slightly more effective than N1-hydroxy-N8-phenyloctanediamide (SAHA, Vorinostat, 1). In a xenograft tumor model, 11, at doses of 100 or 200 mg/kg orally, suppresses the growth of PC-3 cells and leads to tumor growth inhibition of 38.8% and 57.9%, respectively. Compound 11 is a lead compound for further development of potential prostate cancer inhibitors.
Date:	2015-01
Relation:	European Journal of Medicinal Chemistry. 2015 Jan;89:320-330.
Link to:	http://dx.doi.org/10.1016/j.ejmech.2014.10.052
JIF/Ranking 2023:	http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0223-5234&DestApp=IC2JCR
Cited Times(WOS):	https://www.webofscience.com/wos/woscc/full-record/WOS:000348003500029
Cited Times(Scopus):	http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84908277134
Appears in Collections:	[Teng-Kuang Yeh] Periodical Articles

Files in This Item:

File	Description	Size	Format
SDO0223523414009805.pdf		1176Kb	Adobe PDF	673	View/Open

Loading...